CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Variable Lease, Cost
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Variable Lease, Cost of $40.13 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for the quarter ending 2021-12-25 was $1.80M, a 24.16% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for the quarter ending 2021-09-25 was $1.18M, a 23.91% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for the quarter ending 2021-06-26 was $751.00K, a 29.62% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for the quarter ending 2021-03-27 was $883.00K, a 15.50% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for fiscal 2025 was $40.13M, a 37.48% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for fiscal 2024 was $29.19M, a 31.74% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for fiscal 2023 was $22.16M, a 58.68% increase from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. variable lease, cost for fiscal 2022 was $13.96M, a 202.08% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2025-12-27 | $40.13M 10-K · filed 2026-02-18 | ||||
| 2024-12-28 | $29.19M 10-K · filed 2026-02-18 | ||||
| 2023-12-30 | $22.16M 10-K · filed 2026-02-18 | ||||
| 2022-12-31 | $13.96M 10-K · filed 2025-02-19 | ||||
| 2021-12-25 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $2.99M derived: sum of 2 quarters · filed 2024-02-14 | $3.74M derived: sum of 3 quarters · filed 2024-02-14 | $4.62M 10-K · filed 2024-02-14 | |
| 2021-09-25 | $1.18M 10-Q · filed 2021-11-03 | $1.94M derived: sum of 2 quarters · filed 2021-11-03 | $2.82M 10-Q · filed 2021-11-03 | $4.27M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-26 | $751.00K 10-Q · filed 2021-08-04 | $1.64M 10-Q · filed 2021-08-04 | $3.09M derived: sum of 3 quarters · filed 2023-02-22 | $4.64M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-27 | $883.00K 10-Q · filed 2021-05-04 | $2.34M derived: sum of 2 quarters · filed 2023-02-22 | $3.89M derived: sum of 3 quarters · filed 2023-02-22 | $4.96M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-26 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.01M derived: sum of 2 quarters · filed 2023-02-22 | $4.08M derived: sum of 3 quarters · filed 2023-02-22 | $5.12M 10-K · filed 2023-02-22 | |
| 2020-09-26 | $1.56M 10-Q · filed 2021-11-03 | $2.62M derived: sum of 2 quarters · filed 2021-11-03 | $3.67M 10-Q · filed 2021-11-03 | $4.92M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-27 | $1.07M 10-Q · filed 2021-08-04 | $2.11M 10-Q · filed 2021-08-04 | $3.36M derived: sum of 3 quarters · filed 2022-02-16 | $4.01M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-28 | $1.04M 10-Q · filed 2021-05-04 | $2.29M derived: sum of 2 quarters · filed 2022-02-16 | $2.94M derived: sum of 3 quarters · filed 2022-02-16 | $3.87M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-28 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.90M derived: sum of 2 quarters · filed 2022-02-16 | $2.83M derived: sum of 3 quarters · filed 2022-02-16 | $3.16M 10-K · filed 2022-02-16 | |
| 2019-09-28 | $646.00K 10-Q · filed 2020-10-29 | $1.58M derived: sum of 2 quarters · filed 2020-10-29 | $1.91M 10-Q · filed 2020-10-29 | ||
| 2019-06-29 | $930.00K 10-Q · filed 2020-08-05 | $1.26M 10-Q · filed 2020-08-05 | |||
| 2019-03-30 | $335.00K 10-Q · filed 2020-05-07 | $335.00M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |